Webinar Objectives: 

• To identify and debunk common myths and misconceptions about pediatric blood transfusions.
• To provide evidence-based information to correct misunderstandings and improve knowledge
• To discuss case studies and real-world scenarios highlighting common challenges and how they are addressed

Speakers: Dr. Satyam Arora, Regional Director South-East Asia, ISBT Additional Professor, Transfusion Medicine, Post Graduate Institute of Child Health (PGICH), Noida, India  

Webinar Objectives: 

• Explore the basics of  HLA, HPA and tools available
• Platelet Crossmatching
• Approach to a case of Platelet Refractoriness

Speakers: Dr Mohit Chowdhry, Sr. consultant & HEAD - Department of transfusion medicine, molecular biology and transplant immunology ; Indraprastha Apollo hospital, New Delhi

Webinar Objectives: 

• What is CAR-T, CAR-T current indications and future directions
• The patient journey through CAR T-cell therapy and complications associated with CAR-T

Speakers: Ceri Jones Haematology Consultant, University Hospital of Wales, Emily John Lead CAR-T Clinical Nurse Specialist, University Hospital of Wales

Webinar Objectives: 

• Outlining some of the current Iron and PBM activities being used in the UK
• Highlighting differences in practice when managing paediatrics & adults

Speakers: Dr Paolo Polzella and Dr Anne Kelly

Webinar Objectives: 

•  Implementation of goal-directed bleeding management:
  • Coagulation changes during bleeding
  • What is goal directed bleeding management
  • Why bring in viscoelastic testing
  • How do you introduce it
  • Is it effective – impact on blood product usage

Speakers: Kate Maynard, Dr Sam Hird, Dr Amrit Dhadda and Prof Rachel Collis

Webinar Objective:

• LEARNing is fun in a new way when you complete this virtual intensive, transfusion medicine investigation.

Webinar Objectives:

• Worklist Management
• Results Management
• Report Management
• Panel ID | Module
• Archive Management

Speaker:  Gianni Giuffrè

Webinar Objectives:
• Define normal and abnormal coagulation lab findings.
• Correlate laboratory results with common clinical signs and symptoms in the patient.
• Discriminate normal and abnormal platelet laboratory results.
• Apply coagulation and hematology results in case study examples focusing on the provision of appropriate
transfusion of blood products or medical intervention.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Explain detection and identification of red cell alloantibodies.
• Explore problem solving techniques including evaluation of the patient’s clinical and transfusion history, autocontrol, DAT and red cell phenotype.
• Define appropriate testing methods for IgM compared to IgG reactive antibodies.
• Apply antibody identification practices in case studies

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:

•  Advances in treatments for patients with Sickle Cell Disease
•  National Haemoglobinopathy Registry

Speakers: Noemi Roy, Farrukh Shah

Webinar Objectives:

• Blood component usage in the pre hospital setting
• The use of O positive red cells in the pre hospital setting

Speaker: Dr. James Raitt MBChB, FRCEM, FIMC, Kerry Dowling

Webinar Objectives: 

• RhD Case Studies: Interpretation and Patient Risks in Transfusions
• Management of platelet alloimmunization on the Maternity Laboratory
• The challenging effects of monoclonal antibody therapies on the Transfusion Laboratory

Speakers: Dr Lilian Castilho, PhD, Dr Rachel Petermann, MD, PhD, Julie Staves Manager, Transfusion Laboratory

Webinar Objectives: 

• A breakthrough in ABO isoagglutinin titration automation: reason to believe & its benefits

Speakers: Dr. Soma Agrawal

Webinar Objectives: 

• Seeing antibody detection through the lense of Sherlock Holmes

Speaker: Dawn M. Rumsey

Webinar Objectives: 

• Pathophysiology of thrombotic thrombocytopenic purpura (TTP)
• Laboratory characteristics of various ADAMTS13 tests
• Clinical applications of ADAMTS13 testing in diagnostics and management of patients with TTP

Speaker: Dong Chen MD PhD

Webinar Objectives:

• Describe the relationship between Ren Blood cell antigens and their corresponding antibodies
• Learn about genes, antigens, and antibodies and how they are arranged in each system

Speaker: N/A

Webinar Objectives: 

• Review the Serologic Presentation
•  Discuss Adsorption Procedures
• How to differentiate WAIHA from Drug-Induced Hemolytic

Speaker: Sue Johnson MSTM, MT(ASCP)SBB

Webinar Objectives: 

• Discuss antibody development as part of the immune system
• Compare and contrast IgM and IgG class antibodies
• Examine reactivity of IgM and IgG class antibodies in common antibody detection methodologies
• Review publications on clinical significance of IgM and IgG class antibodies

Speaker: Tricia Sanders

Webinar Objectives: 

• Review Chronic Transfusion Therapy (CTT) for Sickle Cell Anemia (SCA)
• Present a prospective study of RBC genotyping of SCA patients and transfused units during CTT
• Clinical applications

Speaker: Marianne E. McPherson Yee, MD

Webinar Objectives: 

• Walk though case studies related to Immunohematology

Speaker: Rebacca Coward, MT (ASCP) SBB^CM

Webinar Objectives: 

• Geneotyping to resolve e-like Antibodies

Speaker: Dr. Shaun Lawicki, MBBS

Webinar Objectives: 

• Recognize serological testing results associated with monoclonal antibody therapy
• Identify when a patient is being treated with monoclonal antibody therapy based on what other drugs the patient is currently on
• Recognize monoclonal antibody therapy drugs that can interfere with serological testing

Speaker: Cynthia Ngo MLS (ASCP)^CM SBB^CM

Webinar Objectives: 

• Describe basic RHD genetics & biochemistry
• Discuss the complexity in the determining RhD antigen status in individuals with a serologic weak D phenotype
• List current recommendations from the participants of the AABB/CAP 2015 working party

Speaker: Sue Johnson MSTM, MT(ASCP)SBB

Webinar Objectives: 

• History of RH
• Nomenclature: Who is right, Who is wrong?
• Lack of RH Gene Expression
• RhD Negative Genotypes in Blacks
• Weak D Polymorphism
• Clinical Considerations for Partial D

Speaker: Joann Moulds, PhD

Webinar Objectives: 

• Identify the genetic mechanism for the inheritance of the ABH blood group antigen, including the Bombay phenotype
• Differentiate the transferases and biochemical structures of the ABH antigens
• Evaluate the characteristics of and relationship between antigens and antibodies in the ABO system
• Identify lectin reagents that show ABO blood groups specifically
• Assess the effects of disease and age on production of ABO antigens and antibodies
• Classify the A and B antigens into subgroups, including serologic characteristics, number of antigen site and frequency in the population

Speaker: LeeAnn Walker, MEd, MT(ASCP)SBB

Webinar Objectives:

• Discuss the purpose of antibody detection testing and techniques.
• Examine reagents used in antibody detection and crossmatch including potentiators and reagent red blood cells.
• Compare antibody detection testing to crossmatch testing

Speaker: Tricia Sanders

Webinar Objectives: 

• Explain the fundamental principles of evaluating reactivity in antibody identification studies
• Understand the differences in ruling-in antibodies (specifically conformation) and ruling-out antibodies (antibody exclusion)
• Perform uncomplicated antibody exclusions and comfirmation
• Discuss exceptions in and limitations of antibody exclusion rules

Speaker: Jan Hamilton MS,MT(ASCP)SBB

Webinar Objectives: 

• Compare and contrast the indirect antiglobulin test (IAT) and direct antiglobulin test (DAT)
• DAT reagents
• Possible causes of a positive DAT
• Elution types with application (Lui, Acid)

Speaker: Jay Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• Review the Rh proteins and Rh genes
• Review Rh terminology
• Illustrate the challenges of serologic Rh antigen typings and how molecular methods can help
• Discuss the AABB recommendations regarding use of RHD genotyping to resolve serologic weak D phenotype
• Use cases to illustrate how RHD genotyping can aid in determination of risk of alloimmunization
• Demonstrate how RH allele matching can be used to find compatible blood for a patient with an antibody to a high prevalence of RH antigen

Speaker: Margaret A. Keller, PhD.

Webinar Objectives: 

• Describe the process for collection of whole blood and apheresis components
• Describe the process for manufacturing components from whole blood
• Define the storage intervals for transfusable blood components
• Describe the process for perioperative blood salvage

Speaker: Heather Vaught, BS, MLS(ASCP)CM SBB

Webinar Objectives: 

• Review shared and unique antigen present on platelets
• Discuss antigen typing & antibody screening/identification
• Touch on disease-specific testing and management strategies

Speaker: Ralph R. Vassallo, MD, FACP

Webinar Objectives: 

• Discuss MNS, Kell, Lewis, Duffy and Kidd blood systems
• Discuss JK alleles that encode weak antigen expression

Speaker: Jill Storry, PhD

Webinar Objectives: 

• How Potentiators work
• IgM vs IgG antibodies
• Antibody Detection Test (IAT)
• Chemical treatment of Red Blood Cells
• W.A.R.M. ^TM  Immucor
• Column Agglutination Testing
• Solid Phase Red Cell Adherence
• The wide array of Potentiators: How to choose and apply

Speaker: Rebecca Coward MT(ASCP) SBB

Webinar Objectives: 

• Define solid phase technology
• Recall the steps for processing a capture Assay
• Interpret Capture results
• Identify the Capture products offered by Immucor

Webinar Objectives: 

• Define and categorize transfusion reactions
• Describe clinical manifestations of specific transfusion reactions
• Discuss patient evaluation and management when transfusion reactions is suspected

Speaker: Margo R Rollins, MD 

Webinar Objectives: 

• Define and categorize transfusion reactions
• Describe clinical manifestations of specific transfusion reactions
• Discuss patient evaluation and management when transfusion reactions is suspected

Speaker: Margo R Rollins, MD 

Webinar Objectives: 

• Hospitals and Blood Donar systems
• Blood Banks and Blood Transfusion
• Patient testing in Blood Banks
• Safe Blood Transfusion
• Blood Collection

Webinar Objectives: 

• Importance and significance in continuing education initiatives within the blood banking community

Speaker: Jay Slayten MS, MT(ASCP)SBB

Webinar Objectives: 

• What is and Red Blood Cell (RBC) and What is its importance
• RBC Critical Functions
• RBC Lifecycle and Membrane Structure
• Antigens on Membrane Surface

Webinar Objectives: 

• Describe the functions of enzymes on red blood cells
• Compare enzyme treatment to chemical treatment
• Discuss the use of enzyme treated red blood cells in antibody detection and identification pathways

Speaker: Tricia Sanders 

Webinar Objectives: 

• Discuss and interpret interactive immunohematology case studies

Speaker: Monica Kalvelage

Webinar Objectives: 

• Review the scope of BeadChip PreciseType^@ testing
• Discuss published indications for RBC genotyping in patients
• Describe Northwestern Memorial Hospital approach
• Examine benefits of DNA phenotyping in subsequent workups
• Discuss questions and comments

Speaker: Glenn Ramsey

Webinar Objectives: 

• Describe the application of molecular testing in the hospital donor center and transfusion service
• Discuss the impact of molecular testing on serologic antibody identification workups through case studies
• List the benefits of leveraging software to simultaniously view serology and molecular testing

Speakers: Jessie Singer MT (ASCP)  Cassandra Josephson MD

Webinar Objectives: 

• Define Monocyte Monolayer Assay (MMA) and determine when it should be considered
• Understand the role of molecular testing in the blood bank
• Evaluate the application of MMA and molecular testing using a case study approach

Speaker: Katrina Bilingsley

Webinar Objectives: 

• Brazilian experience and clinical benefits of blood group genotyping in patents with SCD and thalassemia
• Molecular matching
• RH genotyping in patients with SCD and donors

Speaker: Connie Westhoff, PhD

Webinar Objectives: 

• Introduction to Blood Bank basics
• Discuss limitations of serologic phenotyping
• Description of RBC molecular typing and potential advantages over serologic typing
• Application of RBC molecular typing

Speaker: Ross M Fasano

Webinar Objectives: 

• Echo improvements and their benefits
• ImmuLINK

Speaker: Nancy Harrison 

Webinar Objectives: 

• ImmuLINK function and capabilities
• Hamilton Regional Library medicine program
• CoLabs and ImmuLINK

Speaker: Sandra Fazari MLT, BSC, MBA 

Webinar Objectives: 

• ImmuLINK background
• ImmuLINK demonstration

Speaker: Giuffre Gianni 

Webinar Objectives: 

• ABO Blood group systems
• How does FDA impact ABO Blood groups
• History of blood transfusion
• Landsteiner's Law